Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid:: an improved tool for the diagnosis of fatty acid oxidation defects

被引:72
|
作者
Ventura, FV
Costa, CG
Struys, EA
Ruiter, J
Allers, P
Ijlst, L
de Almeida, T
Duran, M
Jakobs, C
Wanders, RJA
机构
[1] Univ Hosp Amsterdam, AMC, Dept Clin Biochem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Clin Chem, Metab Unit, NL-1081 HV Amsterdam, Netherlands
[3] Univ Childrens Hosp Het Wilhelmina Kinderziekenhu, NL-3501 CA Utrecht, Netherlands
[4] Univ Lisbon, Fac Farm, Ctr Patogenese Mol, P-1600 Lisbon, Portugal
关键词
diagnosis of mitochondrial fatty acid beta-oxidation disorders; inborn errors of metabolism; in vitro acylcarnitines;
D O I
10.1016/S0009-8981(98)00188-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A method was developed for the investigation of mitochondrial fatty acid P-oxidation in cultured fibroblasts. Monolayer cultures were incubated without foetal calf serum with commercially available [U-C-13] palmitic acid and L-carnitine for 96 h. The acylcarnitines produced by the cells were extracted from the cell suspension and analysed either by quantitative stable isotope dilution gas chromatography chemical ionization mass spectrometry, or by fast atom bombardment mass spectrometry. Characteristic acylcarnitine profiles were obtained for all the different enzyme deficiencies investigated, with the exception of carnitine palmitoyltransferase II deficiency and carnitine/acylcarnitine carrier deficiency which showed similar patterns. Comparison between this method and the H-3-myristate and H-3-palmitate tritium release assays revealed that the method described here is superior, allowing unequivocal identification of patients. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 34 条
  • [1] A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid:: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency
    Okun, JG
    Kölker, S
    Schulze, A
    Kohlmüller, D
    Olgemöller, K
    Lindner, M
    Hoffmann, GF
    Wanders, RJA
    Mayatepek, E
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1584 (2-3): : 91 - 98
  • [2] Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects
    Vreken, P
    van Lint, AEM
    Bootsma, AH
    Overmars, H
    Wanders, RJA
    van Gennip, AH
    JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (03) : 302 - 306
  • [3] Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts
    Roe, DS
    Yang, BZ
    Vianey-Saban, C
    Struys, E
    Sweetman, L
    Roe, CR
    MOLECULAR GENETICS AND METABOLISM, 2006, 87 (01) : 40 - 47
  • [4] Quantitative acylcarnitine profiling in peripheral blood mononuclear cells using in vitro loading with palmitic and 2-oxoadipic acids:: Biochemical confirmation of fatty acid oxidation and organic acid disorders
    Schulze-Bergkamen, A
    Okun, JG
    Spiekerkötter, U
    Lindner, M
    Haas, D
    Kohlmüller, D
    Mayatepek, E
    Schulze-Bergkamen, H
    Greenberg, CR
    Zschocke, J
    Hoffmann, GF
    Kölker, S
    PEDIATRIC RESEARCH, 2005, 58 (05) : 873 - 880
  • [5] Quantitative Acylcarnitine Profiling in Peripheral Blood Mononuclear Cells Using In Vitro Loading With Palmitic and 2-Oxoadipic Acids: Biochemical Confirmation of Fatty Acid Oxidation and Organic Acid Disorders
    Andrea Schulze-Bergkamen
    Jürgen G Okun
    Ute Spiekerkötter
    Martin Lindner
    Dorothea Haas
    Dirk Kohlmüller
    Ertan Mayatepek
    Henning Schulze-Bergkamen
    Cheryl R Greenberg
    Johannes Zschocke
    Georg F Hoffmann
    Stefan Kölker
    Pediatric Research, 2005, 58 : 873 - 880
  • [6] Quantitative fibroblast acylcarnitine profiles in mitochondrial fatty acid β-oxidation defects:: phenotype/metabolite correlations
    Sim, KG
    Carpenter, K
    Hammond, J
    Christodoulou, J
    Wilcken, B
    MOLECULAR GENETICS AND METABOLISM, 2002, 76 (04) : 327 - 334
  • [7] MEASUREMENT OF PLASMA-FREE FATTY-ACID TURNOVER AND OXIDATION USING [1-C-13]PALMITIC ACID
    WOLFE, RR
    EVANS, JE
    MULLANY, CJ
    BURKE, JF
    BIOMEDICAL MASS SPECTROMETRY, 1980, 7 (04): : 168 - 171
  • [8] Detection of fatty acid oxidation defects using simultaneous measurements of total fatty acid β-oxidation flux and acylcarnitine profiling in fibroblasts cultured with 2H31-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry
    Law, L. K.
    Tang, N. L. S.
    Hui, J.
    Pang, E. W. H.
    Ho, C. S.
    Ruiter, J.
    Fok, T. F.
    Wanders, R. J. A.
    Lam, C. W. K.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 46 - 46
  • [9] Free fatty acid flux measured using [1-11C]palmitate positron emission tomography and [U-13C]palmitate in humans
    Han, Qiaojun
    Cao, Yanli
    Gathaiya, Nicola
    Kemp, Bradley J.
    Jensen, Michael D.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2018, 314 (05): : E413 - E417
  • [10] Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects
    Fuda, F
    Narayan, SB
    Squires, RH
    Bennett, MJ
    CLINICA CHIMICA ACTA, 2006, 367 (1-2) : 185 - 188